KY HB502 | 2019 | Regular Session
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on February 20 2019 - 25% progression, died in committee
Action: 2019-02-21 - to Banking & Insurance (H)
Pending: House Banking and Insurance Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 20 2019 - 25% progression, died in committee
Action: 2019-02-21 - to Banking & Insurance (H)
Pending: House Banking and Insurance Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Create new sections of KRS Chapter 217 to define terms; require the Cabinet for Health and Family Services to annually compile a list of certain prescription drugs deemed to be essential to treating diabetes and a list of such drugs that have been subject to a price increase greater than a certain percentage; require drug manufacturers to annually report to the cabinet certain information related to the cost of manufacturing and marketing such drugs and factors that contributed to a price increase; require pharmacy benefit managers to annually report to the cabinet certain information related to prescription drug rebates for such drugs; exempt such information and data reported by manufacturers and pharmacy benefit managers to the cabinet from disclosure pursuant to KRS 61.870 to 61.884; require the cabinet to annually submit to the Legislative Research Commission a report that summarizes the information reported to the cabinet by manufacturers and pharmacy benefit managers; require the cabinet to promulgate administrative regulations necessary to carry out the new sections; amend KRS 217.990 to establish a penalty for failure to report; amend KRS 304.17A-164 to restrict cost-sharing amounts charged by insurers and pharmacy benefit managers; prohibit insurers and pharmacy benefit managers from restricting a pharmacist's ability to inform patients about and to sell less expensive alternative drugs; and amend KRS 304.17A-505 and 304.17C-030 to require disclosure of information related to drug formularies.
Title
AN ACT relating to prescription drugs.
Sponsors
History
Date | Chamber | Action |
---|---|---|
2019-02-21 | House | to Banking & Insurance (H) |
2019-02-20 | House | introduced in House |
Subjects
Administrative Regulations and Proceedings
Diseases
Drugs and Medicines
Insurance, Health
Pharmacists
Reports Mandated
Diseases
Drugs and Medicines
Insurance, Health
Pharmacists
Reports Mandated
Kentucky State Sources
Type | Source |
---|---|
Summary | https://apps.legislature.ky.gov/record/19RS/hb502.html |
Text | https://apps.legislature.ky.gov/recorddocuments/bill/19RS/hb502/orig_bill.pdf |